Table 1. Patient characteristics and indication of fiducial placement.
| N (%) | ||
| Gender | Males | 181 (51 %) |
| Females | 174 (49 %) | |
| Age | Mean | 68.5 (34– 92 years) |
| Cancer | Pancreatic adenocarcinoma | 298 |
| Cholangiocarcinoma | 16 | |
| RCC with pancreatic metastases | 10 | |
| Hepatocellular carcinoma | 7 | |
| Pancreatic neuroendocrine tumor | 5 | |
| Esophageal carcinoma | 4 | |
| Gall bladder carcinoma | 3 | |
| Ampullary carcinoma | 3 | |
| Stomach adenocarcinoma | 2 | |
| Metastatic melanoma with peripancreatic mass at portal confluence | 1 | |
| Intraductal papillary mucinous Neoplasm with malignant transformation | 2 | |
| SCC metastases in head of pancreas | 1 | |
| Prostate cancer with metastases in head of pancreas | 1 | |
| Ovarian cancer with metastases in head of pancreas | 1 | |
| Colon cancer with liver metastases | 1 | |
| Tumor consistency | Solid | 343 |
| Cystic | 3 | |
| Mixed | 9 | |
| Tumor size | Average size | 2.86 cm |
| Ill-defined masses (n) | 49 |
RCC, renal cell carcinoma; SCC, squamous cell carcinoma.